VEXTF (VEXTF) Stock Price & Analysis
VEXTF (VEXTF) rose 1.08% to USD 0.17 as of July 25, 2026 at 10:44 UTC, according to Nexqual real-time market data.
VEXTF last closed at USD 0.17; the session ranged USD 0.17–0.18 on volume of 57,000 shares. Market capitalization is $43.02M, with a 52-week range of USD 0.1–0.32 (OQX). Source: Nexqual, July 25, 2026 at 10:44 UTC.
Key Statistics (as of July 25, 2026 at 10:44 UTC)
| Price | USD 0.17 |
|---|---|
| Change | ▲ 1.08% (up) |
| Previous Close | USD 0.17 |
| Open | USD 0.17 |
| Day Range | USD 0.17 – 0.18 |
| 52-Week Range | USD 0.1 – 0.32 |
| Volume | 57,000 shares |
| Market Cap | $43.02M |
| Exchange | OQX |
Technical Analysis (VEXTF)
Nexqual's technical model rates VEXTF "NEUTRAL" based on 2 bullish and 3 bearish signals across 125 daily candles, as of July 25, 2026 at 10:44 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 47.19 (neutral) |
| vs SMA50 | Below (USD 0.18) |
| MACD | -0 (negative) |
Analyst Ratings (VEXTF)
Wall Street analysts rate VEXTF "None" based on 1 analysts, with a mean price target of USD 0.6 (range USD 0.6–0.6), per Nexqual as of July 25, 2026 at 10:44 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 0.6 |
| High Target | USD 0.6 |
| Low Target | USD 0.6 |
| Buy / Hold / Sell | 2 / 0 / 0 |
Earnings (VEXTF)
| Next Earnings Date | 2026-08-19 |
|---|---|
| Revenue Estimate | $12.30M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0 vs est -0.01 ▲ beat |
| 2025-12-31 | USD -0.04 vs est -0.02 ▼ miss |
| 2025-09-30 | USD -0.01 vs est -0.01 ▼ miss |
| 2025-06-30 | USD -0.01 vs est -0.01 ▲ beat |
Source: Nexqual, July 25, 2026 at 10:44 UTC.
Financials & Fundamentals (VEXTF)
| Total Revenue | $51.97M |
|---|---|
| Revenue Growth (YoY) | +5.20% |
| Gross Margin | +34.06% |
| Operating Margin | +0.00% |
| Profit Margin | -29.93% |
| ROE | -24.50% |
| Debt / Equity | 62.35 |
| Current Ratio | 0.62 |
| Total Cash | $5.54M |
| Total Debt | $33.97M |
| Free Cash Flow | $21.56M |
Source: Nexqual, July 25, 2026 at 10:44 UTC.
Financial Health Score (VEXTF)
Nexqual rates VEXTF's overall financial health "Solid" across five dimensions, as of July 25, 2026 at 10:44 UTC.
| Growth | Strong — Revenue +43% YoY (annual) |
|---|---|
| Profitability | Mixed — Gross margin 34%, operating 0% |
| Balance Sheet | Mixed — $6M cash vs $34M debt |
| Cash Flow | Strong — FCF $22M, 42% margin |
| Efficiency | Critical — ROE -24%, ROA -2.5% |
Ownership (VEXTF)
| Insider Ownership | +45.69% |
|---|---|
| Institutional Ownership | +0.35% |
| Shares Outstanding | 185.79M |
| Float | 101.64M |
Source: Nexqual, July 25, 2026 at 10:44 UTC.
Leadership (VEXTF)
VEXTF is led by Eric J. Offenberger, CEO, COO, President & Director, per Nexqual as of July 25, 2026 at 10:44 UTC.
| CEO, COO, President & Director | Eric J. Offenberger |
|---|---|
| Founder & Director | Jason Thai Nguyen |
| Chief Financial Officer | Trevor Smith |
Major Backers & Investors (VEXTF)
Notable institutional backers of VEXTF include AdvisorShares Trust-AdvisorShares Pure US Cannabis ETF, Gofen & Glossberg LLC, according to Nexqual as of July 25, 2026 at 10:44 UTC.
Active Investors
| Investor | Stake |
|---|---|
| AdvisorShares Trust-AdvisorShares Pure US Cannabis ETF | 6.01% |
| Gofen & Glossberg LLC | 0.12% |
Source: Nexqual, July 25, 2026 at 10:44 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CXXIF | C21 Investments Inc. | USD 0.21 | ▼ 6.39% |
| LOWLF | LOWELL FARMS INC. | USD 0 | ▲ 0% |
| CNTMF | FLUENT CORP | USD 0.02 | ▼ 14.29% |
| FFNTF | 4Front Ventures Corp. | USD 0 | ▲ 0% |
| SHWZ | Medicine Man Technologies Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 10:44 UTC. This page is informational and not investment advice.